Issei Tsukamoto, SVP, Head of Business Development, Astellas Pharma Inc.
Advertisement
Articles by Issei Tsukamoto, SVP, Head of Business Development, Astellas Pharma Inc.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Targeting CCR5 Receptors
2
Merck to Acquire Cidara for $9.2 Billion
3
Komzifti Gains FDA Approval, Giving Kura Oncology and Kyowa Kirin a Key Strategic Win in NPM1-Mutated AML
4
Invictus Pharmacy Becomes First US Pharmacy to Accept Cryptocurrency for Prescriptions
5
